1. Ryan MM (2018) Acute promyelocytic leukemia: a Summary. J Adv Pract Oncol 9(2):178–187 Epub 2018 Mar 1. PMID: 30588352; PMCID: PMC6303006
2. Melnick A, Licht JD (1999) Deconstructing a disease: RAR, its Fusion partners, and their roles in the pathogenesis of Acute promyelocytic leukemia. Blood J Am Soc Hematol 93(10):3167–3215
3. de Thé H, Chomienne C, Lanotte M et al (1990) The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347(6293):558–561
4. Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M et al (2000) Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Francais De CytogenetiqueHematologique, Groupe De Francaisd’HematologieCellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action Molecular Cytogenetic diagnosis in Haematological Malignancies. Blood 96(4):1297–1308 PMid:10942371
5. Sanz MA, Lo CF, Martin G, Avvisati G, Rayon C, Barbui T et al (2000) Definition of relapse risk and role of non-anthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 96:1247–1253